Sirolimus Tablet
Product Images NDC 70518-3546

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 70518-3546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Sirolimus 0.5 mg oral tablet label by RemedyRepack Inc. The label states a quantity of 100 tablets per box and includes medication safety warnings, storage instructions, and repackaging information. Manufacturer identified as Ascend Labs, LLC, Montvale, NJ.*

FDA Label Image

Mm2 (Sirolimus 0.5mg 70518 3546 01)

Sirolimus 0.5 mg tablet label by RemedyRepack Inc. The label shows one tablet quantity, oral use, and includes a barcode and QR code. Manufacturer information lists Ascend Labs, LLC, Montvale, NJ. Directions advise seeing the package insert and storage between 20-25°C with permitted excursions. Repackaged by RemedyRepack Inc., Indiana, PA.*

FDA Label Image

Siro01 (Siro01)

Chemical structure diagram of Sirolimus, showing its molecular arrangement with various functional groups and stereochemistry indicated by wedge and dashed bonds. The structure includes multiple ring systems, methyl groups, hydroxyl groups, and oxygen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.